Pharmaceutical Services
Conditions
Interventions
This is a randomized controlled two-arm clinical trial. The sample will consist of 92 patients of both genders, aged over 18 years. After recruitment, participants will be divided into intervention an
L01.462.500.847.698.249
Sponsors
Carla Daniely Pombal Bianchini
Centro Universitário Faculdade de Medicina do ABC
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients aged 18 years or older, of both sexes, with a diagnosis of HF syndrome will be included: HF with reduced ejection fraction or preserved HF, as defined by the Brazilian Guidelines for Chronic and Acute Heart Failure (2018), in use of drug treatment. The selection will take place at Centro Universitário FMABC (HF Ambulatory), with patients that are using medicine treatments.
Exclusion criteria
Exclusion criteria: Patient being evaluated for heart transplantation; patient being evaluated for use of a ventricular assist device; severe lung disease; neoplasm; patient with renal dysfunction and need for dialysis and patient with cognitive difficulties that prevent the completion of the study questionnaires.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The evolution of responses in the applied questionnaires and data analysis will be considered as an outcome: Test of knowledge and adherence (Test Med Take, BMQ); Quality of life (SF 36); Drug Therapy Problems; Hospital admissions (frequency and number of days of hospitalization); Functional test (6-minute walk test) and Attendance to return appointments at the pharmaceutical consultation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Advice on smoking cessation (% of patients with a history of smoking, who were advised to quit smoking and received advice during the pharmaceutical appointment): % of patients instructed and willing to stop after pharmaceutical advice; Advice on diets and explanations about nutrition: weight control during the study; Clarification about the pathology to the family X treatment evolution. | — |
Countries
Brazil
Contacts
Public ContactCarla Daniely Bianchini
Centro Universitário FMABC
Outcome results
None listed